Geriatric Oncology
Cancer incidence increases with age. With an ageing population, the burden of cancer in older people is set to increase significantly in the coming decades. This is a heterogeneous group with wide variations in health and functional status separate from chronological age. Data suggest that historica...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-12-01
|
Series: | Forum of Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/fco-2014-0007 |
id |
doaj-7a591918733f46e28b9d59f9da0a8d43 |
---|---|
record_format |
Article |
spelling |
doaj-7a591918733f46e28b9d59f9da0a8d432021-09-05T21:00:54ZengSciendoForum of Clinical Oncology1792-362X2014-12-015281110.2478/fco-2014-0007Geriatric OncologyHughes Helen0Swaminathan Vikram1Pellegrini Alice2Audisio Riccardo3 FY2, Medicine, Royal Liverpool University Hospital, UK CT1, Orthopaedics, Countess of Chester Hospital, UK Breast Surgery, S. Orsola-Malpighi Hospital, Bologna, Italy Consultant Surgical Oncologist, University of Liverpool and St Helens, Teaching HospitalCancer incidence increases with age. With an ageing population, the burden of cancer in older people is set to increase significantly in the coming decades. This is a heterogeneous group with wide variations in health and functional status separate from chronological age. Data suggest that historically this patient cohort have poorer outcomes and have been under-represented in clinical cancer trials. There is an emerging body of evidence to help guide treatment; however, ongoing research is needed to develop comprehensive evidence-based guidelines and identify treatment regimens, which are suitable for frailer patients. In this article, we review the current field of geriatric oncology. We highlight that age is not a contradiction to cancer treatment but geriatric assessment is needed to identify which treatment a patient may tolerate and benefit from.https://doi.org/10.2478/fco-2014-0007geriatric oncologyelderlycancerfrailty |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hughes Helen Swaminathan Vikram Pellegrini Alice Audisio Riccardo |
spellingShingle |
Hughes Helen Swaminathan Vikram Pellegrini Alice Audisio Riccardo Geriatric Oncology Forum of Clinical Oncology geriatric oncology elderly cancer frailty |
author_facet |
Hughes Helen Swaminathan Vikram Pellegrini Alice Audisio Riccardo |
author_sort |
Hughes Helen |
title |
Geriatric Oncology |
title_short |
Geriatric Oncology |
title_full |
Geriatric Oncology |
title_fullStr |
Geriatric Oncology |
title_full_unstemmed |
Geriatric Oncology |
title_sort |
geriatric oncology |
publisher |
Sciendo |
series |
Forum of Clinical Oncology |
issn |
1792-362X |
publishDate |
2014-12-01 |
description |
Cancer incidence increases with age. With an ageing population, the burden of cancer in older people is set to increase significantly in the coming decades. This is a heterogeneous group with wide variations in health and functional status separate from chronological age. Data suggest that historically this patient cohort have poorer outcomes and have been under-represented in clinical cancer trials. There is an emerging body of evidence to help guide treatment; however, ongoing research is needed to develop comprehensive evidence-based guidelines and identify treatment regimens, which are suitable for frailer patients. In this article, we review the current field of geriatric oncology. We highlight that age is not a contradiction to cancer treatment but geriatric assessment is needed to identify which treatment a patient may tolerate and benefit from. |
topic |
geriatric oncology elderly cancer frailty |
url |
https://doi.org/10.2478/fco-2014-0007 |
work_keys_str_mv |
AT hugheshelen geriatriconcology AT swaminathanvikram geriatriconcology AT pellegrinialice geriatriconcology AT audisioriccardo geriatriconcology |
_version_ |
1717782061648969728 |